for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Updated

BRIEF-Immunovaccine Q2 loss per share C$0.02

By Reuters Staff

Aug 8 (Reuters) - Immunovaccine Inc:

* Immunovaccine announces financial results for quarter ended June 30, 2017

* Q2 basic loss per share c$0.02 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up